Cable Hill Partners, LLC Exact Sciences Corp Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$89.51 - $118.04 $3,759 - $4,957	-42 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$48.29 - $80.6 $1,400 - $2,337	-29 Reduced 40.85%	42 $3,000
Q2 2018 Aug 03, 2018	SELL	$37.84 - $69.96 $2,421 - $4,477	-64 Reduced 47.41%	71 $4,000
Q1 2018 Apr 20, 2018	SELL	$39.82 - $57.53 $9,078 - $13,116	-228 Reduced 62.81%	135 $5,000
Q3 2017 Oct 27, 2017	SELL	$37.05 - $47.12 $222 - $282	-6 Reduced 1.63%	363 $17,000
Q2 2017 Aug 14, 2017	BUY	N/A	369	369 $13,000

672

163M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $11B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.